Chemotherapy Market: Global Industry Trends, Growth, and Forecast
The Chemotherapy Market is experiencing significant growth as cancer incidence continues to rise globally and healthcare systems expand access to oncology treatments. According to Market Research Future, the global market was valued at USD 32.18 billion in 2025 and is projected to reach USD 80.45 billion by 2035, expanding at a CAGR of 10.21% during 2026–2035.
The market includes different drug classes such as alkylating agents, antimetabolites, mitotic inhibitors, topoisomerase inhibitors, and antitumor antibiotics. Chemotherapy continues to play an important role in the treatment of various cancers, including breast, lung, colorectal, prostate, stomach, ovarian, and blood cancers.
Growing cancer prevalence, increasing oncology spending, improvements in chemotherapy delivery, and expanding healthcare infrastructure are among the major factors supporting market growth.
North America currently represents the largest regional market, while Asia-Pacific is expected to experience rapid expansion due to increasing healthcare investments, cancer-care infrastructure development, and growing pharmaceutical capabilities.
The increasing adoption of oral chemotherapy, combination therapies, antibody-drug conjugates, and personalized treatment approaches is also reshaping the future of the global chemotherapy industry.